Electromed, Inc. announced the appointment of Christopher Holland as Chief Commercial Officer. Mr. Holland, an accomplished sales and marketing veteran, brings 30 years of experience in driving commercial growth in the Medical Technology market to Electromed. Prior to joining Electromed, Holland was the Vice President of Commercialization at Prosomnus Sleep Technologies, Inc.
Electromedical Technologies, Inc.
Equities
EMED
US28540Q1004
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 USD | +8.70% | 0.00% | -28.57% |
1st Jan change | Capi. | |
---|---|---|
-28.57% | 225K | |
+8.56% | 219B | |
+7.09% | 183B | |
+11.03% | 133B | |
+25.32% | 108B | |
+0.27% | 63.06B | |
+12.97% | 52.02B | |
+3.96% | 48.2B | |
+0.28% | 40.37B | |
+13.63% | 39.35B |
- Stock Market
- Equities
- EMED Stock
- News Electromedical Technologies, Inc.
- Electromed, Inc., Appoints Christopher Holland as Chief Commercial Officer